How can we explain the sudden 20% drop in sales of Stryker's Prime TC transport chair in European markets during the last month?

Introduction

The sudden 20% drop in sales of Stryker's Prime TC transport chair in European markets during the last month is a critical issue that demands immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a seasonal component. Has this drop coincided with any particular season or holiday period in Europe?

Why it matters: Seasonal trends could explain temporary fluctuations. Expected answer: No significant seasonal correlation. Impact on approach: If seasonal, we'd focus on inventory management and forecasting.

• Considering the specificity of the product, I'm wondering about regulatory changes. Have there been any recent medical device regulations implemented in the EU?

Why it matters: Regulatory changes could impact product approval or distribution. Expected answer: No major regulatory changes in the past month. Impact on approach: If regulatory, we'd prioritize compliance and potential product modifications.

• Given the European focus, I'm curious about market dynamics. Has there been any significant competitor activity or new product launches in this space recently?

Why it matters: Competitive pressures could explain a sudden shift in market share. Expected answer: No major competitor actions noted. Impact on approach: If competitive, we'd focus on product differentiation and marketing strategies.

• Thinking about internal factors, have there been any recent changes to the product, pricing, or distribution channels?

Why it matters: Internal changes could inadvertently impact sales. Expected answer: No significant internal changes reported. Impact on approach: If internal, we'd review recent decisions and their implementation.

• Considering data integrity, has there been any change in how sales are reported or measured across European markets?

Why it matters: Ensures we're not dealing with a data anomaly rather than a true sales drop. Expected answer: No changes in reporting methods. Impact on approach: If data issue, we'd focus on reconciling reporting discrepancies.